Glycolytic Inhibitor Shows Potential in Protecting Against Type 1 Diabetes in Animal Models
Researchers at Kobe University found that oral administration of the glycolytic inhibitor 2-deoxy-D-glucose suppressed autoimmune diabetes progression in mouse models by altering immune cell activity.
Key points
- Oral 2DG treatment suppressed type 1 diabetes progression in mouse models.
- The compound altered immune cell populations, increasing regulatory T cells.
- Findings remain limited to preclinical animal studies and require clinical validation.
A study published in Nature Health Sciences by researchers from Kobe University investigated the effects of the glycolytic inhibitor 2-deoxy-D-glucose (2DG) on type 1 diabetes development. Type 1 diabetes is an autoimmune condition driven by T cells destroying pancreatic beta cells. To explore potential interventions, the research team administered oral 2DG to two distinct mouse models of type 1 diabetes.
Findings in Animal Models
In the first evaluation using a cyclophosphamide-induced model in male non-obese diabetic mice, oral 2DG treatment successfully suppressed autoimmune insulitis and the onset of diabetes. The treatment led to a notable drop in CD44hiCD4+ T cells and CD11b+ macrophages, alongside an increase in regulatory T cells (Tregs) and protective PD-L1+ macrophages. A second evaluation using a spontaneous model in female mice yielded similar outcomes, reinforcing that 2DG may limit autoimmune progression and reduce insulitis.
What to know: This study was conducted exclusively in animal models, meaning these preliminary results cannot yet be directly extrapolated to human patients. The findings suggest that metabolic regulation—specifically via reduced glucose uptake in immune cells like B cells—may influence autoimmune responses, but further clinical research is required. Readers should consult a qualified healthcare professional for guidance regarding any personal medical decisions or diabetes management.
Source Nature Health Sciences — nature.com/articles/s41598-026-70088-2 ↗
Read next
🧠Mind & Mental HealthAddressing Body Image and the Reality of Gluteal Anatomy
A personal reflection on the social and psychological impact of body shape, specifically regarding the gluteal region, and the limitations of consumer solutions for perce…
❤️Conditions & CareMigraine and Smoking Linked to Increased Early Stroke Risk in Women
A large-scale study suggests that people who have given birth and experience migraines while also smoking face a significantly higher risk of stroke before age 60.
🔬ResearchCBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities
A double-blind clinical trial published in JAMA Pediatrics indicates that CBD oil provides no significant behavioral improvement for children and teenagers with intellect…
🏃FitnessExpert Advice on Hydration Gear Sparks Debate Among Recreational Runners
Olympic medalist Josh Kerr recently suggested that runners may not require hydration packs for distances under 12 miles, igniting a broader conversation about gear necess…
🏃FitnessA Structured Approach to Beginning a Strength and Cardio Routine
A new four-week training program offers beginners a guided path to incorporating strength training and cardiovascular exercise into their daily lives.
🧠Mind & Mental HealthThe Role of Daily Mobility Training in Managing Sedentary Tension
A two-week personal trial suggests that incorporating short, daily mobility exercises may help alleviate stiffness associated with sedentary desk work. Experts note that …